These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11598362)

  • 41. [Expression and significance of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
    Zhao EM; Han DM; Yu ZK; Fan EZ; Li Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):39-42. PubMed ID: 12778766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells.
    Hu XY; Ma YH; Wang C; Yang YH
    Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancer.
    Plas E; Carroll VA; Jilch R; Simak R; Mihaly J; Melchior S; Thüroff JW; Binder BR; Pflüger H
    Cytometry; 2001 Jun; 46(3):184-9. PubMed ID: 11449410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of chronic allograft rejection on plasma regulators of fibrinolysis.
    Perkowska A; Elhasade A; Durlik M; Placha G; Gałazka Z; Lao M; Gaciong Z
    Ann Transplant; 2002; 7(1):44-51. PubMed ID: 12221903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The expression of plasminogen activator system in a rat model of periodontal wound healing.
    Xiao Y; Li H; Bunn C; Bartold PM
    J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
    Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
    Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical relevance of uPA, uPAR, PAI 1 and PAI 2 tissue expression and plasma PAI 1 level in colorectal carcinoma patients.
    Halamkova J; Kiss I; Pavlovsky Z; Jarkovsky J; Tomasek J; Tucek S; Hanakova L; Moulis M; Cech Z; Zavrelova J; Penka M
    Hepatogastroenterology; 2011; 58(112):1918-25. PubMed ID: 22234062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prognostic value of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
    Zhao E; Han D; Yu Z; Fan E; Li Y; Zhou Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Nov; 16(11):599-602. PubMed ID: 15515548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An ELISA avoiding interference by heterophilic antibodies in the measurement of components of the plasminogen activation system in blood.
    Grebenchtchikov N; Sweep CG; Geurts-Moespot A; Piffanelli A; Foekens JA; Benraad TJ
    J Immunol Methods; 2002 Oct; 268(2):219-31. PubMed ID: 12215390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia.
    Estellés A; Gilabert J; España F; Aznar J; Galbis M
    Am J Obstet Gynecol; 1991 Jul; 165(1):138-42. PubMed ID: 1906680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients.
    Borstnar S; Vrhovec I; Svetic B; Cufer T
    Clin Breast Cancer; 2002 Jun; 3(2):138-46. PubMed ID: 12123538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.
    Kaminski TW; Pawlak K; Karbowska M; Mysliwiec M; Grzegorzewski W; Kuna J; Pawlak D
    Int Urol Nephrol; 2018 Jan; 50(1):127-135. PubMed ID: 29058166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
    Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders.
    Sartori MT; Serena A; Saggiorato G; Campei S; Faggian D; Pagnan A; Paternoster DM
    J Thromb Haemost; 2008 Feb; 6(2):352-8. PubMed ID: 18021302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dissemination risk index based on plasminogen activator system components in primary breast cancer.
    Bouchet C; Hacène K; Martin PM; Becette V; Tubiana-Hulin M; Lasry S; Oglobine J; Spyratos F
    J Clin Oncol; 1999 Oct; 17(10):3048-57. PubMed ID: 10506599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
    Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
    Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Urokinase and tissue type plasminogen activators and their type-1 inhibitor (PAI-1) in gastric cancer].
    Gerstein ES; Shcherbakov AM; Kaz'min AI; Ognerubov NA; Kushlinskiĭ NE
    Vopr Onkol; 2003; 49(2):165-9. PubMed ID: 12785198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD
    Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study.
    van den Berg VJ; Bouwens E; Umans VAWM; de Maat M; Manintveld OC; Caliskan K; Constantinescu AA; Mouthaan H; Cornel JH; Baart S; Akkerhuis KM; Boersma E; Kardys I
    Thromb Haemost; 2019 Dec; 119(12):1947-1955. PubMed ID: 31659734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative effects of pulsatile and nonpulsatile flow on plasma fibrinolytic balance in pediatric patients undergoing cardiopulmonary bypass.
    Aĝirbaşli MA; Song J; Lei F; Wang S; Kunselman AR; Clark JB; Myers JL; Ündar A
    Artif Organs; 2014 Jan; 38(1):28-33. PubMed ID: 24237252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.